Preparation and nanoencapsulation of l-asparaginase II in chitosan-tripolyphosphate nanoparticles and in vitro release study

Nanoscale Research Letters

Volumn 9, Issue 1, 2014, Pages 1-13

  Bahreini, Elham ^a   Aghaiypour, Khosrow ^b   Abbasalipourkabir, Roghayeh ^a   Mokarram, Ali Rezaei ^b   Goodarzi, Mohammad Taghi ^a   Saidijam, Massoud ^a  

^a HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b RAZI VACCINE AND SERUM RESEARCH INSTITUTE   (Iran)

Author keywords

Cross linking; Enzyme immobilization; Half life; Ionotropic gelation; Nanoparticle; Optimization

Indexed keywords

CHEMOTHERAPY; CHITOSAN; CLONING; CONTROLLED DRUG DELIVERY; EFFICIENCY; ENZYME IMMOBILIZATION; ESCHERICHIA COLI; FOURIER TRANSFORM INFRARED SPECTROSCOPY; HIGH RESOLUTION TRANSMISSION ELECTRON MICROSCOPY; IONOTROPIC GELATION; NANOPARTICLES; OPTIMIZATION; TARGETED DRUG DELIVERY;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANTINEOPLASTIC AGENTS; CHITOSAN NANOPARTICLES; CONCEPTUAL UNDERSTANDING; ENCAPSULATION EFFICIENCY; HALF LIVES; HIGH MOLECULAR WEIGHT PROTEIN; MORPHOLOGICAL OBSERVATIONS;

LOADING;

EID: 84925490613     PISSN: 19317573     EISSN: 1556276X     Source Type: Journal    
DOI: 10.1186/1556-276X-9-340     Document Type: Article

References (51)

1. Narta UK, Kanwar SS, Azmi W: Pharmacological and clinical evaluation of L-asparaginase in the treatment of leukemia. Crit Rev Oncol Hematol 2007, 61: 208-221. 10. 1016/j. critrevonc. 2006. 07. 009.
2. Pasut G, Sergi M, Veronese FM: Anti-cancer PEG-enzymes: 30 years old, but still a current approach. Adv Drug Deliv Rev 2008, 60: 69-78. 10. 1016/j. addr. 2007. 04. 018.
3. Wolf M, Wirth M, Pittner F, Gabor F: Stabilisation and determination of the biological activity of L-asparaginase in poly(D, L-lactide-co-glycolide) nanospheres. Int J Pharm 2003, 256: 141-152. 10. 1016/S0378-5173(03)00071-1.
4. Matsushima A, Nishimura H, Ashihara Y, Yokota Y, Inada Y: Modification ofE. coliasparaginase with 2, 4-bis(O-methoxypolyethylene glycol)-6-chloro-S-triazine(activated PEG2); disappearance of binding ability towards anti-serum and retention of enzymic activity. Chem Lett 1980, 103: 773-776.
5. Uren JR, Hargis BJ, Beardsley P: Immunological and pharmacological characterization of poly-DL-alanyl-modifiedErwinia carotovoraL-asparaginase. Cancer Res 1982, 42: 4068-4071.
6. Wileman T, Foster RL, Elliot PNC: Soluble asparaginase-dextran conjugates show increased circulatory persistence and lowered antigen reactivity. J Pharm Pharmacol 1986, 38: 264-271. 10. 1111/j. 2042-7158. 1986. tb04564. x.
7. Gaspar MM, Perez-Soler R, Cruz ME: Biological characterization of L-asparaginase liposomal formulations. Cancer Chemother Pharmacol 1996, 38: 373-377. 10. 1007/s002800050497.
8. Gasper MM, Blanco D, Cruz ME, Alonso MJ: Formulation of L-asparaginase-loaded poly(lactide-co-glycolide) nanocapsules: influence of polymer properties on enzyme loading, activity and in vitro release. J Control Release 1998, 52: 53-62. 10. 1016/S0168-3659(97)00196-X.
9. Teodor E, Litescu SC, Lazar V, Somoghi R: Hydrogel-magnetic nanoparticles with immobilized L-asparaginase for biomedical applications. J Mater Sci Mater Med 2009, 20: 1307-1314. 10. 1007/s10856-008-3684-y.
10. Bhattarai N, Ramay HR, Chou SH, Zhang M: Chitosan and lactic acid-grafted chitosan nanoparticles as carriers for prolonged drug delivery. Int J Nanomedicine 2006, 1: 181-187. 10. 2147/nano. 2006. 1. 2. 181.
11. Bernkop-Schnürch A: Chitosan and its derivatives: potential excipients for peroral peptide delivery systems. Int J Pharm 2000, 194: 1-13. 10. 1016/S0378-5173(99)00365-8.
12. Guang Liu W, De Yao K: Chitosan and its derivatives-a promising non-viral vector for gene transfection. J Control Release 2002, 83: 1-11. 10. 1016/S0168-3659(02)00144-X.
13. Bodmeier R, Chen HG, Paeratakul O: A novel approach to the oral delivery of micro and nanoparticles. Pharm Res 1989, 6: 413-417. 10. 1023/A: 1015987516796.
14. Calvo P, Remuñán-López C, Vila-Jato JL, Alonso MJ: Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers. J Appl Polym Sci 1997, 63: 125-132. 10. 1002/(SICI)1097-4628(19970103)63: 1<125:: AID-APP13>3. 0. CO;2-4.
15. Sun P, Li P, Li YM, Wei Q, Tian LH: A pH-sensitive chitosan-tripolyphosphate hydrogel beads for controlled glipizide delivery. J Biomed Mater Res B Appl Biomater 2011, 97: 175-183.
16. Wang JJ, Zeng ZW, Xiao RZ, Xie T, Zhou GL, Zhan GL, Shu Ling Wang SL: Recent advances of chitosan nanoparticles as drug carriers. Int J Nanomedicine 2011, 6: 765-774.
17. Wang N, Gunn J, Zhang M: Chitosan-based hydrogels for controlled, localized drug delivery. Adv Drug Deliv Rev 2010, 62: 83-99. 10. 1016/j. addr. 2009. 07. 019.
18. Zhang HL, Wu SH, Tao Y, Zang LQ, Su ZQ: Preparation and characterization of water-soluble chitosan nanoparticles as protein delivery system. J Nano Mat 2010, 2010: 1-5.
19. Bahreini E, Aghaiypour K, Abbasalipourkabir R, Goodarzi MT, Saidijam M, Safavieh SS: An optimized protocol for over-production of recombinant protein expression inEscherichia coli. Prep Biochem Biotechnol 2014, 44: 510-528. 10. 1080/10826068. 2013. 833116.
20. Imada A, Igarasi S, Nakahama K, Isono M: Asparaginase and glutaminase activities of micro-organisms. J Gen Microbiol 1973, 76: 85-99. 10. 1099/00221287-76-1-85.
21. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the folin phenol regent. J Biol Chem 1951, 193: 265-275.
22. Kawashima Y, Handa T, Kasai A, Takenaka H, Lin SY, Ando Y: Novel method for the preparation of controlled-release theophylline granules coated with a polyelectrolyte complex of sodium polyphosphate-chitosan. J Pharm Sci 1985, 74: 264-268. 10. 1002/jps. 2600740308.
23. Harms E, Wehner A, Aung HP, Röhm KH: A catalytic role for threonine-12 ofE. coliasparaginase II as established by site-directed mutagenesis. FEBS Lett 1991, 285: 55-58. 10. 1016/0014-5793(91)80723-G.
24. Bajaj G, van Alstine WG, Yeo Y: Zwitterionic chitosan derivative, a new biocompatible pharmaceutical excipient, prevents endotoxin-mediated cytokine release. PLoS One 2012, 7: e30899. 10. 1371/journal. pone. 0030899.
25. Mao HQ, Roy K, Troung-Le VL, Janes KA, Lin KY, Wang Y, August JT, Leong KW: Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. J Control Release 2001, 70: 399-421. 10. 1016/S0168-3659(00)00361-8.
26. Greenquist AC, Wriston JC Jr: Chemical evidence for identical subunits in L-asparaginase fromEscherichia coliB. Arch Biochem Biophys 1972, 152: 280-286. 10. 1016/0003-9861(72)90216-0.
27. Swain AL, Jaskólski M, Housset D, Rao JK, Wlodawer A: Crystal structure ofEscherichia coliL-asparaginase, an enzyme used in cancer therapy. Proc Natl Acad Sci U S A 1993, 90: 1474-1478. 10. 1073/pnas. 90. 4. 1474.
28. Huang Y, Lapitsky Y: Monovalent salt enhances colloidal stability during the formation of chitosan/tripolyphosphate microgels. Langmuir 2011, 27: 10392-10399. 10. 1021/la201194a.
29. Gan Q, Wang T: Chitosan nanoparticles as protein delivery carrier-systematic examination of fabrication conditions for efficient loading and release. Colloids Surf B: Biointerfaces 2007, 59: 24-34. 10. 1016/j. colsurfb. 2007. 04. 009.
30. Lavertu M, Méthot S, Tran-Khanh N, Buschmann MD: High efficiency gene transfer using chitosan/DNA nanoparticles with specific combinations of molecular weight and degree of deacetylation. Biomaterials 2006, 27: 4815-4824. 10. 1016/j. biomaterials. 2006. 04. 029.
31. López-León T, Carvalho EL, Seijo B, Ortega-Vinuesa JL, Bastos-González D, Ortega-Vinuesa JL, Bastos-González D: Physicochemical characterization of chitosan nanoparticles: electrokinetic and stability behavior. J Colloid Interface Sci 2005, 283: 344-351. 10. 1016/j. jcis. 2004. 08. 186.
32. Alsarra IA, Neau SH, Howard MA: Effects of preparative parameters on the properties of chitosan hydrogel beads containingCandida rugosalipase. Biomaterials 2004, 25: 2645-2655. 10. 1016/j. biomaterials. 2003. 09. 051.
33. Wang R, Xia B, Li BJ, Peng SL, Ding LS, Zhang S: Semi-permeable nanocapsules of konjac glucomannan-chitosan for enzyme immobilization. Int J Pharm 2008, 364: 102-107. 10. 1016/j. ijpharm. 2008. 07. 026.
34. De Jong WH, Borm PJ: Drug delivery and nanoparticles: applications and hazards. Int J Nanomedicine 2008, 3: 133-149.
35. Nagpal K, Singh SK, Mishra DN: Chitosan nanoparticles: a promising system in novel drug delivery. Chem Pharm Bull (Tokyo) 2010, 58: 1423-1430. 10. 1248/cpb. 58. 1423.
36. Yoshida H, Nishihara H, Kataoka T: Adsorption of BSA on strongly basic chitosan: equilibria. Biotechnol Bioeng 1994, 43: 1087-1093. 10. 1002/bit. 260431112.
37. Lee DW, Powers K, Baney R: Physicochemical properties and blood compatibility of acylated chitosan nanoparticles. Carbohyd Polym 2004, 58: 371-377. 10. 1016/j. carbpol. 2004. 06. 033.
38. Wu Y, Yang W, Wang C, Hu J, Fu S: Chitosan nanoparticles as a novel delivery system for ammonium glycyrrhizinate. Int J Pharm 2005, 295: 235-245. 10. 1016/j. ijpharm. 2005. 01. 042.
39. Knaul JZ, Hudson SM, Creber KAM: Improved mechanical properties of chitosan fibers. J Appl Polym Sci 1999, 72: 1721-1732. 10. 1002/(SICI)1097-4628(19990624)72: 13<1721:: AID-APP8>3. 0. CO;2-V.
40. Xu Y, Du Y: Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles. Int J Pharm 2003, 250: 215-226. 10. 1016/S0378-5173(02)00548-3.
41. Yang YM, Hu W, Wang XD, Gu XS: The controlling biodegradation of chitosan fibers by N-acetylation in vitro and in vivo. J Mater Sci Mater Med 2007, 18: 2117-2121. 10. 1007/s10856-007-3013-x.
42. Amidi M, Mastrobattista E, Jiskoot W, Hennink WE: Chitosan-based delivery systems for protein therapeutics and antigens. Adv Drug Deliv Rev 2010, 62: 59-82. 10. 1016/j. addr. 2009. 11. 009.
43. Wang AZ, Gu F, Zhang L, Chan JM, Radovic-Moreno A, Shaikh MR, Farokhzad OC: Biofunctionalized targeted nanoparticles for therapeutic applications. Expert Opin Biol Ther 2008, 8: 1063-1070. 10. 1517/14712598. 8. 8. 1063.
44. Leroux L, Hatim Z, Frèche M, Lacout JL: Effects of various adjuvants (lactic acid, glycerol, and chitosan) on the injectability of a calcium phosphate cement. Bone 1999, 25: 31-34. 10. 1016/S8756-3282(99)00130-1.
45. Singh A, Narvi SS, Dutta PK, Pandey ND: External stimuli response on a novel chitosan hydrogel crosslinked with formaldehyde. Bull Mater Sci 2006, 29: 233-238. 10. 1007/BF02706490.
46. Giannotti MI, Esteban O, Oliva M, García-Parajo MAF, Sanz F: pH-responsive polysaccharide-based polyelectrolyte complexes as nanocarriers for lysosomal delivery of therapeutic proteins. Biomacromolecules 2011, 12: 2524-2533. 10. 1021/bm2003384.
47. Shu XZ, Zhu KJ: A novel approach to prepare tripolyphosphate/chitosan complex beads for controlled release drug delivery. Int J Pharm 2000, 201: 51-58. 10. 1016/S0378-5173(00)00403-8.
48. Massart R: Preparation of aqueous magnetic liquids in alkaline and acidic media. IEEE Trans Magn 1981, 17: 1247-1248. 10. 1109/TMAG. 1981. 1061188.
49. Klibanov AL, Maruyama K, Torchilin VP, Huang L: Amphipatic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett 1990, 268: 235-238. 10. 1016/0014-5793(90)81016-H.
50. Torchilin VP: Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discovery 2005, 4: 145-160. 10. 1038/nrd1632.
51. Torchilin VP, Omelyanenko VG, Papisov MI, Bogdanov AA Jr, Trubetskoy VS, Herron JN, Gentry CA: Poly(ethylene glycol) on the liposome surface: on the mechanism of polymer-coated liposome longevity. Biochim Biophys Acta 1994, 1195: 11-20. 10. 1016/0005-2736(94)90003-5.